Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO25472 | Garcinia cowa | Species | Clusiaceae | Eukaryota | Flowers | Pakook, Muang District, Chiang Rai Province, Thailand | 2013-FEB |
PMID[25651042] |
NPO6249 | Garcinia mangostana | Species | Clusiaceae | Eukaryota | stem bark | Pangradin village, Jasinga, West Java, Indonesia | 2005-AUG |
PMID[19839614] |
NPO6249 | Garcinia mangostana | Species | Clusiaceae | Eukaryota | UNPD* | |||
NPO8560 | Aplidium tabascum | Species | Polyclinidae | Eukaryota | UNPD* | |||
NPO10056 | Nicotiana sylvestris | Species | Solanaceae | Eukaryota | UNPD* | |||
NPO10391 | Dolomiaea souliei | Species | Asteraceae | Eukaryota | UNPD* | |||
NPO9520 | Cratoxylum sumatranum | Species | Hypericaceae | Eukaryota | UNPD* | |||
NPO6106 | Hymeniacidon perlevis | Species | Halichondriidae | Eukaryota | UNPD* | |||
NPO3449 | Lonicera hypoleuca | Species | Caprifoliaceae | Eukaryota | UNPD* | |||
NPO19227 | Hippoglossus hippoglossus | Species | Pleuronectidae | Eukaryota | UNPD* | |||
NPO11770 | Amphicome emodi | NA | NA | NA | UNPD* | |||
NPO19560 | Populus italica | Species | Salicaceae | Eukaryota | UNPD* | |||
NPO7534 | Leptogorgia sarmentosa | Species | Gorgoniidae | Eukaryota | UNPD* | |||
NPO18995 | Gaultheria itoana | Species | Ericaceae | Eukaryota | UNPD* | |||
NPO18657 | Galanthus gracilis | Species | Amaryllidaceae | Eukaryota | UNPD* | |||
NPO16038 | Ribes rubrum | Species | Grossulariaceae | Eukaryota | UNPD* | |||
NPO9741 | Actinopyga agassizi | Species | Holothuriidae | Eukaryota | UNPD* | |||
NPO8927 | Poria selecta | Species | Coccinellidae | Eukaryota | UNPD* | |||
NPO9717 | Wibelia divaricata | Species | Davalliaceae | Eukaryota | UNPD* | |||
NPO10376 | Arcyria denudata | Species | Trichiidae | Eukaryota | UNPD* | |||
NPO8354 | Aster bellidiastrum | Species | Asteraceae | Eukaryota | UNPD* | |||
NPO27924 | Serpocaulon triseriale | Species | Polypodiaceae | Eukaryota | UNPD* | |||
NPO24931 | Myelochroa aurulenta | Species | Parmeliaceae | Eukaryota | UNPD* | |||
NPO12600 | Trametes cinnabarina | Species | Coriolaceae | Eukaryota | UNPD* | |||
NPO18783 | Garcinia fusca | Species | Clusiaceae | Eukaryota |
PMID[12608849] |
|||
NPO19359 | Parmotrema delicatulum | Species | Parmeliaceae | Eukaryota | UNPD* | |||
NPO24928 | Cratoxylum cochinchinense | Species | Hypericaceae | Eukaryota | TCMID* | |||
NPO22337 | Garcinia dulcis | Species | Clusiaceae | Eukaryota | TCMID* | |||
NPO13263 | Verbena brasiliensis | Species | Verbenaceae | Eukaryota | UNPD* | |||
NPO6249 | Garcinia mangostana | Species | Clusiaceae | Eukaryota | TCMID* | |||
NPO7811 | Scleronephthya pallida | Species | Nephtheidae | Eukaryota | UNPD* | |||
NPO14950 | Ardisia polycephala | Species | Primulaceae | Eukaryota | UNPD* | |||
NPO19501 | Pseudosuberites hyalinus | Species | Suberitidae | Eukaryota | UNPD* | |||
NPO3707 | Chromatium okenii | Species | Chromatiaceae | Bacteria | UNPD* | |||
NPO10849 | Eucalyptus camaldulensis | Species | Myrtaceae | Eukaryota | UNPD* | |||
NPO25216 | Senecio vellereus | Species | Asteraceae | Eukaryota | UNPD* | |||
NPO4064 | Halimodendron halodendron | Species | Fabaceae | Eukaryota | UNPD* | |||
NPO16745 | Scorzonera judaica | Species | Asteraceae | Eukaryota | UNPD* | |||
NPO17438 | Polygala virgata | Species | Polygalaceae | Eukaryota | UNPD* | |||
NPO10221 | Streptomyces alboniger | Species | Streptomycetaceae | Bacteria | UNPD* | |||
NPO18005 | Artemisia leucodes | Species | Asteraceae | Eukaryota | UNPD* |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT116 | Cell Line | HL-60 | Homo sapiens | IC50 | = | 7600 | nM | 12932141 |
NPT2 | Others | Unspecified | Inhibition | = | 0 | % | 12608849 | |
NPT2 | Others | Unspecified | Inhibition | = | 20.5 | % | 12608849 | |
NPT2 | Others | Unspecified | Inhibition | = | 62.6 | % | 12608849 | |
NPT2 | Others | Unspecified | Inhibition | = | 90.4 | % | 12608849 | |
NPT2 | Others | Unspecified | IC50 | = | 270 | molar ratio | 12608849 | |
NPT80 | Cell Line | Raji | Homo sapiens | Activity | = | 70 | % | 12608849 |
NPT80 | Cell Line | Raji | Homo sapiens | Activity | > | 80 | % | 12608849 |
NPT139 | Cell Line | HT-29 | Homo sapiens | ED50 | = | 1.7 | nM | 19839614 |
NPT163 | Individual Protein | Nuclear factor NF-kappa-B p105 subunit | Homo sapiens | IC50 | = | 7500 | nM | 19839614 |
NPT721 | Individual Protein | Nuclear factor NF-kappa-B p65 subunit | Homo sapiens | IC50 | = | 12100 | nM | 19839614 |
NPT344 | Individual Protein | Sialidase | Clostridium perfringens | IC50 | = | 60700 | nM | 20696581 |
NPT344 | Individual Protein | Sialidase | Clostridium perfringens | Ki | = | 24900 | nM | 20696581 |
NPT865 | Individual Protein | Fatty acid synthase | Homo sapiens | IC50 | = | 24830 | nM | 20817450 |
NPT2 | Others | Unspecified | Inhibition | = | 73.1 | % | 25651042 | |
NPT2 | Others | Unspecified | IC50 | = | 8700 | nM | 25651042 | |
NPT314 | Organism | Bacillus cereus | Bacillus cereus | MIC | = | 16 | ug/ml | 25651042 |
NPT79 | Organism | Bacillus subtilis | Bacillus subtilis | MIC | = | 4 | ug/ml | 25651042 |
NPT16 | Organism | Staphylococcus aureus | Staphylococcus aureus | MIC | > | 128 | ug/ml | 25651042 |
NPT19 | Organism | Escherichia coli | Escherichia coli | MIC | > | 128 | ug/ml | 25651042 |
NPT566 | Organism | Salmonella typhimurium | Salmonella enterica subsp. enterica serovar Typhimurium | MIC | = | 128 | ug/ml | 25651042 |
NPT18 | Organism | Pseudomonas aeruginosa | Pseudomonas aeruginosa | MIC | = | 128 | ug/ml | 25651042 |
NPT861 | Individual Protein | Isocitrate dehydrogenase [NADP] cytoplasmic | Homo sapiens | Ki | = | 12000 | nM | 26508549 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC14353 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
1.0 | High Similarity | NPC228785 |
1.0 | High Similarity | NPC56085 |
0.9934 | High Similarity | NPC278052 |
0.9934 | High Similarity | NPC61010 |
0.9934 | High Similarity | NPC100123 |
0.9934 | High Similarity | NPC40491 |
0.9868 | High Similarity | NPC241904 |
0.9868 | High Similarity | NPC300727 |
0.9868 | High Similarity | NPC320359 |
0.9868 | High Similarity | NPC217677 |
0.9868 | High Similarity | NPC165977 |
0.9805 | High Similarity | NPC236132 |
0.9805 | High Similarity | NPC248638 |
0.9805 | High Similarity | NPC152659 |
0.9805 | High Similarity | NPC236521 |
0.9805 | High Similarity | NPC220313 |
0.9805 | High Similarity | NPC7483 |
0.9803 | High Similarity | NPC476242 |
0.9801 | High Similarity | NPC274730 |
0.9801 | High Similarity | NPC142339 |
0.9742 | High Similarity | NPC326520 |
0.9742 | High Similarity | NPC275780 |
0.9742 | High Similarity | NPC472450 |
0.9742 | High Similarity | NPC239752 |
0.974 | High Similarity | NPC25152 |
0.9739 | High Similarity | NPC475886 |
0.9739 | High Similarity | NPC474287 |
0.9737 | High Similarity | NPC262286 |
0.9737 | High Similarity | NPC36852 |
0.9737 | High Similarity | NPC78225 |
0.9737 | High Similarity | NPC236796 |
0.9679 | High Similarity | NPC170245 |
0.9679 | High Similarity | NPC39091 |
0.9677 | High Similarity | NPC23298 |
0.9677 | High Similarity | NPC189473 |
0.9677 | High Similarity | NPC270837 |
0.9675 | High Similarity | NPC475883 |
0.9675 | High Similarity | NPC32694 |
0.9675 | High Similarity | NPC474187 |
0.9675 | High Similarity | NPC474186 |
0.9675 | High Similarity | NPC474351 |
0.9671 | High Similarity | NPC68093 |
0.9671 | High Similarity | NPC138243 |
0.9671 | High Similarity | NPC191146 |
0.9669 | High Similarity | NPC89474 |
0.9618 | High Similarity | NPC6588 |
0.9618 | High Similarity | NPC117854 |
0.9618 | High Similarity | NPC477154 |
0.9613 | High Similarity | NPC229632 |
0.9613 | High Similarity | NPC294965 |
0.961 | High Similarity | NPC235018 |
0.961 | High Similarity | NPC36217 |
0.961 | High Similarity | NPC119224 |
0.961 | High Similarity | NPC200746 |
0.961 | High Similarity | NPC45146 |
0.9608 | High Similarity | NPC136674 |
0.9608 | High Similarity | NPC469584 |
0.9608 | High Similarity | NPC223787 |
0.9605 | High Similarity | NPC113906 |
0.9554 | High Similarity | NPC472449 |
0.9554 | High Similarity | NPC37870 |
0.9551 | High Similarity | NPC146134 |
0.9551 | High Similarity | NPC474350 |
0.9551 | High Similarity | NPC197168 |
0.9551 | High Similarity | NPC475985 |
0.9551 | High Similarity | NPC41301 |
0.9548 | High Similarity | NPC266314 |
0.9548 | High Similarity | NPC66288 |
0.9545 | High Similarity | NPC250214 |
0.9545 | High Similarity | NPC329091 |
0.9545 | High Similarity | NPC235448 |
0.9545 | High Similarity | NPC95936 |
0.9536 | High Similarity | NPC202157 |
0.949 | High Similarity | NPC473286 |
0.949 | High Similarity | NPC25361 |
0.9487 | High Similarity | NPC52204 |
0.9487 | High Similarity | NPC83922 |
0.9487 | High Similarity | NPC470694 |
0.9487 | High Similarity | NPC472448 |
0.9487 | High Similarity | NPC201800 |
0.9487 | High Similarity | NPC329760 |
0.9484 | High Similarity | NPC204290 |
0.9484 | High Similarity | NPC471973 |
0.9484 | High Similarity | NPC139036 |
0.9484 | High Similarity | NPC246478 |
0.9484 | High Similarity | NPC476980 |
0.9484 | High Similarity | NPC80375 |
0.9481 | High Similarity | NPC472914 |
0.9481 | High Similarity | NPC162869 |
0.9481 | High Similarity | NPC156057 |
0.9481 | High Similarity | NPC245758 |
0.9481 | High Similarity | NPC474208 |
0.9481 | High Similarity | NPC472911 |
0.9481 | High Similarity | NPC475267 |
0.9481 | High Similarity | NPC474836 |
0.9481 | High Similarity | NPC222814 |
0.9481 | High Similarity | NPC472910 |
0.9481 | High Similarity | NPC96167 |
0.9481 | High Similarity | NPC472913 |
0.9481 | High Similarity | NPC48208 |
0.9477 | High Similarity | NPC117992 |
0.9477 | High Similarity | NPC230149 |
0.9477 | High Similarity | NPC45849 |
0.9477 | High Similarity | NPC200761 |
0.9477 | High Similarity | NPC57674 |
0.9477 | High Similarity | NPC470327 |
0.9477 | High Similarity | NPC168247 |
0.9477 | High Similarity | NPC152951 |
0.9477 | High Similarity | NPC477503 |
0.9474 | High Similarity | NPC101996 |
0.9474 | High Similarity | NPC471982 |
0.9474 | High Similarity | NPC120537 |
0.9474 | High Similarity | NPC199100 |
0.9474 | High Similarity | NPC180234 |
0.947 | High Similarity | NPC151473 |
0.9427 | High Similarity | NPC186686 |
0.9427 | High Similarity | NPC207690 |
0.9423 | High Similarity | NPC472275 |
0.9423 | High Similarity | NPC167678 |
0.9423 | High Similarity | NPC258331 |
0.9423 | High Similarity | NPC29876 |
0.9419 | High Similarity | NPC210459 |
0.9419 | High Similarity | NPC185258 |
0.9419 | High Similarity | NPC85121 |
0.9419 | High Similarity | NPC172770 |
0.9419 | High Similarity | NPC474290 |
0.9416 | High Similarity | NPC209614 |
0.9416 | High Similarity | NPC235165 |
0.9416 | High Similarity | NPC35038 |
0.9416 | High Similarity | NPC195796 |
0.9416 | High Similarity | NPC472916 |
0.9416 | High Similarity | NPC472626 |
0.9416 | High Similarity | NPC255106 |
0.9416 | High Similarity | NPC291878 |
0.9416 | High Similarity | NPC470328 |
0.9416 | High Similarity | NPC278778 |
0.9412 | High Similarity | NPC88645 |
0.9412 | High Similarity | NPC69394 |
0.9412 | High Similarity | NPC183878 |
0.9412 | High Similarity | NPC271779 |
0.9412 | High Similarity | NPC145379 |
0.9412 | High Similarity | NPC292214 |
0.9412 | High Similarity | NPC227337 |
0.9412 | High Similarity | NPC255350 |
0.9412 | High Similarity | NPC273462 |
0.9412 | High Similarity | NPC206238 |
0.9412 | High Similarity | NPC231018 |
0.9412 | High Similarity | NPC47781 |
0.9412 | High Similarity | NPC22519 |
0.9412 | High Similarity | NPC250822 |
0.9412 | High Similarity | NPC49402 |
0.9412 | High Similarity | NPC176775 |
0.9412 | High Similarity | NPC70433 |
0.9412 | High Similarity | NPC276409 |
0.9412 | High Similarity | NPC75279 |
0.9412 | High Similarity | NPC33051 |
0.9412 | High Similarity | NPC274327 |
0.9412 | High Similarity | NPC160951 |
0.9412 | High Similarity | NPC167091 |
0.9408 | High Similarity | NPC171010 |
0.9408 | High Similarity | NPC117579 |
0.9367 | High Similarity | NPC293319 |
0.9367 | High Similarity | NPC475888 |
0.9363 | High Similarity | NPC211107 |
0.9363 | High Similarity | NPC474150 |
0.9363 | High Similarity | NPC81679 |
0.9363 | High Similarity | NPC474162 |
0.9359 | High Similarity | NPC321399 |
0.9359 | High Similarity | NPC84571 |
0.9359 | High Similarity | NPC299436 |
0.9355 | High Similarity | NPC210084 |
0.9355 | High Similarity | NPC79053 |
0.9355 | High Similarity | NPC181960 |
0.9355 | High Similarity | NPC299520 |
0.9355 | High Similarity | NPC474055 |
0.9355 | High Similarity | NPC291508 |
0.9355 | High Similarity | NPC476981 |
0.9355 | High Similarity | NPC99597 |
0.9355 | High Similarity | NPC180011 |
0.9355 | High Similarity | NPC129684 |
0.9355 | High Similarity | NPC27337 |
0.9355 | High Similarity | NPC161960 |
0.9355 | High Similarity | NPC304008 |
0.9355 | High Similarity | NPC472598 |
0.9355 | High Similarity | NPC187745 |
0.9355 | High Similarity | NPC219867 |
0.9355 | High Similarity | NPC472963 |
0.9351 | High Similarity | NPC20830 |
0.9351 | High Similarity | NPC183597 |
0.9351 | High Similarity | NPC130589 |
0.9351 | High Similarity | NPC37392 |
0.9351 | High Similarity | NPC227325 |
0.9351 | High Similarity | NPC256612 |
0.9351 | High Similarity | NPC134287 |
0.9351 | High Similarity | NPC50715 |
0.9351 | High Similarity | NPC128863 |
0.9351 | High Similarity | NPC208197 |
0.9351 | High Similarity | NPC2476 |
0.9351 | High Similarity | NPC201136 |
0.9351 | High Similarity | NPC472909 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC14353 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.9412 | High Similarity | NPD2801 | Approved |
0.9286 | High Similarity | NPD2393 | Clinical (unspecified phase) |
0.9221 | High Similarity | NPD1934 | Approved |
0.8875 | High Similarity | NPD5494 | Approved |
0.8824 | High Similarity | NPD1511 | Approved |
0.8805 | High Similarity | NPD3882 | Suspended |
0.8773 | High Similarity | NPD6167 | Clinical (unspecified phase) |
0.8773 | High Similarity | NPD6168 | Clinical (unspecified phase) |
0.8773 | High Similarity | NPD6166 | Phase 2 |
0.8765 | High Similarity | NPD6232 | Discontinued |
0.872 | High Similarity | NPD7473 | Discontinued |
0.871 | High Similarity | NPD1512 | Approved |
0.8645 | High Similarity | NPD4378 | Clinical (unspecified phase) |
0.8614 | High Similarity | NPD5844 | Phase 1 |
0.8571 | High Similarity | NPD4868 | Clinical (unspecified phase) |
0.8563 | High Similarity | NPD7074 | Phase 3 |
0.8562 | High Similarity | NPD1465 | Phase 2 |
0.8562 | High Similarity | NPD7819 | Suspended |
0.8554 | High Similarity | NPD3818 | Discontinued |
0.8521 | High Similarity | NPD4338 | Clinical (unspecified phase) |
0.8509 | High Similarity | NPD3817 | Phase 2 |
0.8503 | High Similarity | NPD7054 | Approved |
0.8491 | Intermediate Similarity | NPD4380 | Phase 2 |
0.8476 | Intermediate Similarity | NPD6959 | Discontinued |
0.8452 | Intermediate Similarity | NPD7472 | Approved |
0.8405 | Intermediate Similarity | NPD7075 | Discontinued |
0.8333 | Intermediate Similarity | NPD7096 | Clinical (unspecified phase) |
0.8312 | Intermediate Similarity | NPD1552 | Clinical (unspecified phase) |
0.8312 | Intermediate Similarity | NPD1550 | Clinical (unspecified phase) |
0.8294 | Intermediate Similarity | NPD6797 | Phase 2 |
0.8282 | Intermediate Similarity | NPD8443 | Clinical (unspecified phase) |
0.8258 | Intermediate Similarity | NPD1549 | Phase 2 |
0.8246 | Intermediate Similarity | NPD7251 | Discontinued |
0.8198 | Intermediate Similarity | NPD7808 | Phase 3 |
0.8182 | Intermediate Similarity | NPD4381 | Clinical (unspecified phase) |
0.8176 | Intermediate Similarity | NPD2534 | Approved |
0.8176 | Intermediate Similarity | NPD2533 | Approved |
0.8176 | Intermediate Similarity | NPD7410 | Clinical (unspecified phase) |
0.8176 | Intermediate Similarity | NPD2532 | Approved |
0.8144 | Intermediate Similarity | NPD1247 | Approved |
0.8141 | Intermediate Similarity | NPD970 | Clinical (unspecified phase) |
0.8098 | Intermediate Similarity | NPD7411 | Suspended |
0.8089 | Intermediate Similarity | NPD2800 | Approved |
0.8081 | Intermediate Similarity | NPD7993 | Clinical (unspecified phase) |
0.807 | Intermediate Similarity | NPD7804 | Clinical (unspecified phase) |
0.8065 | Intermediate Similarity | NPD1510 | Phase 2 |
0.8049 | Intermediate Similarity | NPD6801 | Discontinued |
0.8039 | Intermediate Similarity | NPD1240 | Approved |
0.8039 | Intermediate Similarity | NPD943 | Approved |
0.8023 | Intermediate Similarity | NPD8397 | Clinical (unspecified phase) |
0.8013 | Intermediate Similarity | NPD2935 | Discontinued |
0.8013 | Intermediate Similarity | NPD2796 | Approved |
0.8 | Intermediate Similarity | NPD6799 | Approved |
0.7964 | Intermediate Similarity | NPD3749 | Approved |
0.7952 | Intermediate Similarity | NPD5402 | Approved |
0.7949 | Intermediate Similarity | NPD1509 | Clinical (unspecified phase) |
0.7947 | Intermediate Similarity | NPD1530 | Clinical (unspecified phase) |
0.7941 | Intermediate Similarity | NPD3926 | Phase 2 |
0.7935 | Intermediate Similarity | NPD1607 | Approved |
0.7931 | Intermediate Similarity | NPD6559 | Discontinued |
0.7927 | Intermediate Similarity | NPD6599 | Discontinued |
0.7925 | Intermediate Similarity | NPD3750 | Approved |
0.7923 | Intermediate Similarity | NPD7501 | Clinical (unspecified phase) |
0.7917 | Intermediate Similarity | NPD6234 | Discontinued |
0.7895 | Intermediate Similarity | NPD1529 | Clinical (unspecified phase) |
0.7895 | Intermediate Similarity | NPD7852 | Clinical (unspecified phase) |
0.7866 | Intermediate Similarity | NPD3226 | Approved |
0.7848 | Intermediate Similarity | NPD2346 | Discontinued |
0.7834 | Intermediate Similarity | NPD651 | Clinical (unspecified phase) |
0.7833 | Intermediate Similarity | NPD7879 | Clinical (unspecified phase) |
0.7811 | Intermediate Similarity | NPD919 | Approved |
0.7806 | Intermediate Similarity | NPD1612 | Clinical (unspecified phase) |
0.7806 | Intermediate Similarity | NPD1613 | Approved |
0.7798 | Intermediate Similarity | NPD7768 | Phase 2 |
0.7785 | Intermediate Similarity | NPD6100 | Approved |
0.7785 | Intermediate Similarity | NPD6099 | Approved |
0.7778 | Intermediate Similarity | NPD7390 | Discontinued |
0.7756 | Intermediate Similarity | NPD230 | Phase 1 |
0.7725 | Intermediate Similarity | NPD37 | Approved |
0.7719 | Intermediate Similarity | NPD7199 | Phase 2 |
0.7701 | Intermediate Similarity | NPD3751 | Discontinued |
0.7701 | Intermediate Similarity | NPD7228 | Approved |
0.7692 | Intermediate Similarity | NPD4966 | Approved |
0.7692 | Intermediate Similarity | NPD4965 | Approved |
0.7692 | Intermediate Similarity | NPD4967 | Phase 2 |
0.7674 | Intermediate Similarity | NPD5711 | Approved |
0.7674 | Intermediate Similarity | NPD5710 | Approved |
0.7674 | Intermediate Similarity | NPD3787 | Discontinued |
0.7654 | Intermediate Similarity | NPD8055 | Clinical (unspecified phase) |
0.7643 | Intermediate Similarity | NPD447 | Suspended |
0.764 | Intermediate Similarity | NPD7421 | Clinical (unspecified phase) |
0.7636 | Intermediate Similarity | NPD6980 | Clinical (unspecified phase) |
0.763 | Intermediate Similarity | NPD7184 | Clinical (unspecified phase) |
0.7622 | Intermediate Similarity | NPD7422 | Clinical (unspecified phase) |
0.7613 | Intermediate Similarity | NPD3027 | Phase 3 |
0.761 | Intermediate Similarity | NPD3748 | Approved |
0.761 | Intermediate Similarity | NPD2799 | Discontinued |
0.7595 | Intermediate Similarity | NPD6651 | Approved |
0.7542 | Intermediate Similarity | NPD8313 | Approved |
0.7542 | Intermediate Similarity | NPD8312 | Approved |
0.754 | Intermediate Similarity | NPD6782 | Approved |
0.754 | Intermediate Similarity | NPD6777 | Approved |
0.754 | Intermediate Similarity | NPD6780 | Approved |
0.754 | Intermediate Similarity | NPD6776 | Approved |
0.754 | Intermediate Similarity | NPD6779 | Approved |
0.754 | Intermediate Similarity | NPD6781 | Approved |
0.754 | Intermediate Similarity | NPD6778 | Approved |
0.7531 | Intermediate Similarity | NPD1243 | Approved |
0.753 | Intermediate Similarity | NPD920 | Approved |
0.753 | Intermediate Similarity | NPD5403 | Approved |
0.7516 | Intermediate Similarity | NPD2344 | Approved |
0.75 | Intermediate Similarity | NPD4625 | Phase 3 |
0.7486 | Intermediate Similarity | NPD4419 | Clinical (unspecified phase) |
0.7485 | Intermediate Similarity | NPD6398 | Clinical (unspecified phase) |
0.7485 | Intermediate Similarity | NPD4628 | Phase 3 |
0.7485 | Intermediate Similarity | NPD1653 | Approved |
0.7472 | Intermediate Similarity | NPD5953 | Discontinued |
0.7458 | Intermediate Similarity | NPD7286 | Phase 2 |
0.7455 | Intermediate Similarity | NPD6143 | Clinical (unspecified phase) |
0.7453 | Intermediate Similarity | NPD1551 | Phase 2 |
0.7452 | Intermediate Similarity | NPD4907 | Clinical (unspecified phase) |
0.7452 | Intermediate Similarity | NPD6859 | Clinical (unspecified phase) |
0.7452 | Intermediate Similarity | NPD2313 | Discontinued |
0.7421 | Intermediate Similarity | NPD1933 | Approved |
0.7421 | Intermediate Similarity | NPD7435 | Discontinued |
0.7418 | Intermediate Similarity | NPD8150 | Discontinued |
0.741 | Intermediate Similarity | NPD5401 | Approved |
0.741 | Intermediate Similarity | NPD642 | Clinical (unspecified phase) |
0.7409 | Intermediate Similarity | NPD8151 | Discontinued |
0.7372 | Intermediate Similarity | NPD9494 | Approved |
0.7371 | Intermediate Similarity | NPD7229 | Phase 3 |
0.7338 | Intermediate Similarity | NPD4379 | Clinical (unspecified phase) |
0.7333 | Intermediate Similarity | NPD2309 | Approved |
0.7333 | Intermediate Similarity | NPD6190 | Approved |
0.7333 | Intermediate Similarity | NPD7782 | Clinical (unspecified phase) |
0.7333 | Intermediate Similarity | NPD7783 | Phase 2 |
0.733 | Intermediate Similarity | NPD7697 | Approved |
0.733 | Intermediate Similarity | NPD7696 | Phase 3 |
0.733 | Intermediate Similarity | NPD7698 | Approved |
0.7325 | Intermediate Similarity | NPD4908 | Phase 1 |
0.7322 | Intermediate Similarity | NPD8434 | Phase 2 |
0.7292 | Intermediate Similarity | NPD7871 | Phase 2 |
0.7292 | Intermediate Similarity | NPD7870 | Phase 2 |
0.7289 | Intermediate Similarity | NPD643 | Clinical (unspecified phase) |
0.7277 | Intermediate Similarity | NPD6823 | Phase 2 |
0.7273 | Intermediate Similarity | NPD6535 | Approved |
0.7273 | Intermediate Similarity | NPD6534 | Approved |
0.7273 | Intermediate Similarity | NPD1878 | Clinical (unspecified phase) |
0.7273 | Intermediate Similarity | NPD4360 | Phase 2 |
0.7273 | Intermediate Similarity | NPD4363 | Phase 3 |
0.7268 | Intermediate Similarity | NPD7701 | Phase 2 |
0.725 | Intermediate Similarity | NPD4060 | Phase 1 |
0.7244 | Intermediate Similarity | NPD1470 | Approved |
0.7238 | Intermediate Similarity | NPD7685 | Pre-registration |
0.7238 | Intermediate Similarity | NPD7240 | Approved |
0.7235 | Intermediate Similarity | NPD5808 | Clinical (unspecified phase) |
0.7232 | Intermediate Similarity | NPD5242 | Approved |
0.7208 | Intermediate Similarity | NPD1201 | Approved |
0.7208 | Intermediate Similarity | NPD1610 | Phase 2 |
0.7194 | Intermediate Similarity | NPD7874 | Approved |
0.7194 | Intermediate Similarity | NPD7875 | Clinical (unspecified phase) |
0.7191 | Intermediate Similarity | NPD2403 | Approved |
0.7161 | Intermediate Similarity | NPD9269 | Phase 2 |
0.7158 | Intermediate Similarity | NPD7699 | Phase 2 |
0.7158 | Intermediate Similarity | NPD7700 | Phase 2 |
0.7157 | Intermediate Similarity | NPD7801 | Approved |
0.7152 | Intermediate Similarity | NPD2861 | Phase 2 |
0.7151 | Intermediate Similarity | NPD7615 | Clinical (unspecified phase) |
0.7134 | Intermediate Similarity | NPD5408 | Approved |
0.7134 | Intermediate Similarity | NPD1203 | Approved |
0.7134 | Intermediate Similarity | NPD5406 | Approved |
0.7134 | Intermediate Similarity | NPD5404 | Approved |
0.7134 | Intermediate Similarity | NPD5405 | Approved |
0.7126 | Intermediate Similarity | NPD5353 | Approved |
0.7125 | Intermediate Similarity | NPD3268 | Approved |
0.712 | Intermediate Similarity | NPD7090 | Clinical (unspecified phase) |
0.7115 | Intermediate Similarity | NPD4749 | Approved |
0.711 | Intermediate Similarity | NPD6844 | Discontinued |
0.7108 | Intermediate Similarity | NPD6674 | Discontinued |
0.7108 | Intermediate Similarity | NPD5698 | Clinical (unspecified phase) |
0.7105 | Intermediate Similarity | NPD8090 | Clinical (unspecified phase) |
0.7101 | Intermediate Similarity | NPD7004 | Clinical (unspecified phase) |
0.7097 | Intermediate Similarity | NPD1547 | Clinical (unspecified phase) |
0.7091 | Intermediate Similarity | NPD1471 | Phase 3 |
0.7089 | Intermediate Similarity | NPD2798 | Approved |
0.7059 | Intermediate Similarity | NPD4287 | Approved |
0.7059 | Intermediate Similarity | NPD1940 | Clinical (unspecified phase) |
0.7053 | Intermediate Similarity | NPD4361 | Phase 2 |
0.7053 | Intermediate Similarity | NPD4362 | Clinical (unspecified phase) |
0.7051 | Intermediate Similarity | NPD1608 | Approved |
0.7048 | Intermediate Similarity | NPD2424 | Discontinued |
0.7047 | Intermediate Similarity | NPD2494 | Approved |
0.7047 | Intermediate Similarity | NPD2493 | Approved |
0.7041 | Intermediate Similarity | NPD7584 | Approved |
0.7037 | Intermediate Similarity | NPD6213 | Phase 3 |
0.7037 | Intermediate Similarity | NPD6214 | Clinical (unspecified phase) |
0.7037 | Intermediate Similarity | NPD6212 | Phase 3 |
0.7035 | Intermediate Similarity | NPD7458 | Discontinued |
0.7029 | Intermediate Similarity | NPD4288 | Approved |
0.7025 | Intermediate Similarity | NPD2797 | Approved |
PubChem CID   | 5495925 |
ChEMBL   | CHEMBL261706 |
ZINC   |
Molecular Weight:   | 424.19 |
ALogP:   | 2.3127 |
MLogP:   | 3.55 |
XLogP:   | 3.629 |
# Rotatable Bonds:   | 14 |
Polar Surface Area:   | 85.22 |
# H-Bond Aceptor:   | 1 |
# H-Bond Donor:   | 2 |
# Rings:   | 3 |
# Heavy Atoms:   | 31 |